Is individualized medicine on the horizon for lupus? Joan T. Merrill Invited Commentary 16 October 2008 Pages: 257 - 258
Epidemiology of systemic lupus erythematosus: Capturing the butterfly S. Sam LimCristina Drenkard OriginalPaper 16 October 2008 Pages: 265 - 272
The link between vitamin D deficiency and systemic lupus erythematosus Diane L. KamenCynthia Aranow OriginalPaper 16 October 2008 Pages: 273 - 280
The SLICC inception cohort for atherosclerosis Murray B. UrowitzDafna D. Gladman OriginalPaper 16 October 2008 Pages: 281 - 285
Dehydroepiandrosterone in systemic lupus erythematosus Amr H. SawalhaSusan Kovats OriginalPaper 16 October 2008 Pages: 286 - 291
The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis Christopher T. Ritchlin Clinical Trials Report 16 October 2008 Pages: 295 - 296
Remission in psoriatic arthritis Kurt de VlamRik J. U. Lories OriginalPaper 16 October 2008 Pages: 297 - 302
MRI in psoriatic arthritis: Insights into pathogenesis and treatment response Fiona M. McQueenNicola DalbethAnthony Doyle OriginalPaper 16 October 2008 Pages: 303 - 310
Altered bone remodeling in psoriatic arthritis Kofi A. MensahEdward M. SchwarzChristopher T. Ritchlin OriginalPaper 16 October 2008 Pages: 311 - 317
Idiopathic inflammatory myopathy: Treatment options Stephen J. DiMartino OriginalPaper 16 October 2008 Pages: 321 - 327
Inflammatory muscle disease assessment Tim Y. -T. LuKristine P. NgDavid A. Isenberg OriginalPaper 16 October 2008 Pages: 328 - 332
Autoantibodies and their significance in myositis Ira N. Targoff OriginalPaper 16 October 2008 Pages: 333 - 340